CLDI - Calidi Biotherapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Calidi Biotherapeutics, Inc.
IPO Date: November 1, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $2.61M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.09 | 6.96%
Avg Daily Range (30 D): $0.05 | 3.93%
Avg Daily Range (90 D): $0.05 | 5.66%
Institutional Daily Volume
Avg Daily Volume: 2.55M
Avg Daily Volume (30 D): .16M
Avg Daily Volume (90 D): 2.65M
Trade Size
Avg Trade Size (Sh.): 585
Avg Trade Size (Sh.) (30 D): 206
Avg Trade Size (Sh.) (90 D): 754
Institutional Trades
Total Institutional Trades: 3
Avg Institutional Trade: $.67M
Avg Institutional Trade (30 D): $.67M
Avg Institutional Trade (90 D): $.67M
Avg Institutional Trade Volume: M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: K
 
News
Sep 25, 2026 @ 9:00 PM
Calidi Biotherapeutics Received NYSE American Noti...
Source: Na
Jul 20, 2026 @ 8:30 PM
Calidi Announces Reverse Stock Split, Expected to ...
Source: Na
Jun 16, 2026 @ 12:00 PM
Calidi Biotherapeutics Receives Positive Pre-IND F...
Source: Na
May 22, 2026 @ 10:00 PM
Calidi Biotherapeutics Provides Required NYSE Amer...
Source: Na
Mar 10, 2026 @ 12:50 AM
Calidi Biotherapeutics Announces Closing of $6.0 M...
Source: Na
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-2.94 $-.43 $.45
Diluted EPS $-2.94 $-.43 $.45
Revenue $M $M $M
Gross Profit
Net Income / Loss $-4.16M $-4.11M $-4.06M
Operating Income / Loss $-4.15M $-4.19M $-4.47M
Cost of Revenue
Net Cash Flow $-2.57M $1.04M $-4.78M
PE Ratio    
Splits
Jul 31, 2026 1:16
Aug 05, 2025 1:12
Jul 15, 2024 1:10